These Stocks Might Be Good Swing Trades

By Scott Matusow:In this article I wrote on January 23, 2012, I listed several stocks I felt were good short term swing trades. I will go over the original picks, see if they panned out, and grade myself on how I did.Original call: Biosante (BPAX); Might be

By Scott Matusow:Trading Biophama stocks before a catalyst event - if done correctly - can be a very profitable proposition, but if traded in a wrong manner can cause losses.

By Scott Matusow:In a February 27, 2012 article I gave a small list of bio-pharma companies with their drugs that were facing FDA decisions for approval or rejection. I gave FDA decision predictions for each drug. In this article, we will see how my predictions panned out. At the end of this article, I list one more company I feel investors should keep a close eye on as well.

By Scott Matusow:Ariad Pharma (ARIA), 3/2/12 pps: $14.68 Ariad is a biopharmaceutical company that focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.

By Scott Matusow: Columbia Labs ( CBRX) Drug: CRINONE (progesterone gel) CRINONE 8% is a vaginal progesterone gel utilizing our sustained-release bio-adhesive technology indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology treatment for infertile women with a progesterone deficiency.

By Williams Equity Analysis: BioSante Pharmaceuticals (BPAX) is a biotech company based out of Illinois. The stock has risen about 40% since June 20th with the absence of any major news, so there is significant risk of a short-term pullback. Pipeline

By Scott Matusow:Catalyst trades in the bio pharma sector can provide big profits if traded correctly. Some traders and investors who enjoy bringing more risk into play often times will hold through the catalyst event. While this does bring a lot more risk into play, the reward from engaging in this can be a massive one.

By Scott Matusow:On March 5, 2012, I listed 4 bio-pharmas I felt would bring some nice midterm returns for investors/traders. It has been about 3 weeks since I gave these picks, and we are approaching the first leg of the midterm time frame, so let's see how my picks are doing as of their last trading sessions on 3/22/21. The picks were based on the 3/2/12 prices per share.